Clinical Trial Update: Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating BF2.649 with add-on Modafinil for cataplexy in narcolepsy has completed, reporting efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataplexy
• Excessive Daytime Sleepiness
• Narcolepsy

Drugs mentioned

• BF2.649 (BF2.649)
• Modafinil (modafinil)

Snippet

Sponsor: Bioprojet | Conditions: Narcolepsy, Cataplexy | Phase 3 | Status: COMPLETED